Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 11, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$14.6B
sum of reported positions
Reported positions
522
Changes vs prior quarter
505
102 new · 66 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 161 measured positions in 8 quarters, the typical new or larger position finished −2.3 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
TEVA PHARMACEUTICAL INDS LTD | 42.9M | $1.45B | 9.9% |
| 3.51M | $914M | 6.2% | |
SELECT SECTOR SPDR TR | 4.23M | $784M | 5.4% |
ISHARES TR | 4.01M | $579M | 4.0% |
| 1.16M | $553M | 3.8% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $10.5B | $14.6B |
| Positions | 486 | 522 |
| Biggest line | — | TEVA PHARMACEUTICAL INDS LTD 10% |
INVESCO EXCHANGE TRADED FD T |
| 2.31M |
| $491M |
| 3.4% |
| 2.31M | $461M | 3.2% |
| 1.46M | $349M | 2.4% |
| 618K | $335M | 2.3% |
VANGUARD SCOTTSDALE FDS | 3.04M | $323M | 2.2% |
ISHARES TR | 1.28M | $310M | 2.1% |
| 862K | $305M | 2.1% |
| 390K | $297M | 2.0% |
| 795K | $296M | 2.0% |
ISHARES TR | 2.68M | $264M | 1.8% |
| 751K | $256M | 1.7% |
| 646K | $244M | 1.7% |
ISHARES TR | 1.51M | $237M | 1.6% |
| 695K | $201M | 1.4% |
| 808K | $198M | 1.4% |
| 1.37M | $196M | 1.3% |
| 2.08M | $190M | 1.3% |
SELECT SECTOR SPDR TR | 988K | $188M | 1.3% |
| 5.37M | $187M | 1.3% |
ISHARES INC | 4.99M | $172M | 1.2% |
Dover Corporation (DOV)
1,357 → 1,473 shares (+9%)
GE HealthCare (GEHC)
4,498 → 5,131 shares (+14%)
Biogen (BIIB)
1,371 → 1,457 shares (+6%)
Dexcom (DXCM)
3,878 → 4,660 shares (+20%)
Otis Worldwide (OTIS)
3,977 → 4,333 shares (+9%)
ResMed| (RMD)
1,402 → 1,591 shares (+14%)
Copart (CPRT)
9,513 → 11K shares (+14%)
Cognizant (CTSH)
4,752 → 7,671 shares (+61%)
Hubbell Incorporated (HUBB)
532 → 560 shares (+5%)
PPG Industries (PPG)
2,185 → 2,362 shares (+8%)
Verisign (VRSN)
862 → 1,062 shares (+23%)
Church & Dwight (CHD)
2,412 → 2,721 shares (+13%)
Labcorp (LH)
811 → 896 shares (+11%)
Fair Isaac (FICO)
197 → 208 shares (+6%)
CF Industries (CF)
1,567 → 1,968 shares (+26%)
Equifax (EFX)
1,132 → 1,459 shares (+29%)
AeroVironment (AVAV)
1,100 → 1,350 shares (+23%)
Steris (STE)
913 → 1,038 shares (+14%)
Albemarle Corporation (ALB)
1,136 → 1,537 shares (+35%)
CONSTELLATION ENERGY CORP · PUT
50K → 91K shares (+82%)